November 27, 2021
Psyence Group Inc. files Q2 Unaudited Condensed Consolidated Interim Financial Statements and MD&A
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a…
Sandoz completes acquisition of GSK’s cephalosporin business
Sandoz, a Novartis division, has acquired rights to three established brands (Zinnat, Zinacef and Fortum) in more than 100 markets, further reinforcing its leading global position in antibiotics. In 2020,...
LEO Pharma shared new Adtralza results
September 30, 2021
Hikma launches Micafungin for Injection
Hikma Pharmaceuticals has announced it launched Micafungin for Injection through its US affiliate, Hikma Pharmaceuticals USA Inc. The company has launched 50mg and 100mg doses.
Cellbox Solutions kicks off subsidiary in the USA
September 20, 2021
Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19
A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19. The trial, ACTIV-2, is sponsored by the National Institute of Allergy...
Drug testing approach uncovers effective combination for treating small cell lung cancer
Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small...
Scientists find evidence that novel coronavirus infects the mouth’s cells
An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth....
